Company intelligence / Profile preview

Challenge Bioproducts

Douliu City, Yunlin County, Taiwan

Ownership: Private
Development stage: Other

Overview

Challenge Bioproducts supplies commercial bioproducts (proteins, peptides, enzymes, botanical extracts) for pharmaceutical research, bioprocess, and some clinical or applied medical settings. Their products are cited in over 1,000 scientific publications and used in over 52 countries. While they contribute to efforts like the development of new drugs for third-degree burn treatment, they do not have proprietary clinical assets in regulated trials as of 2025.

Therapeutic areas: Psychiatry
Modalities: ProteinPeptidesEnzymeBotanical extracts
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Challenge Bioproducts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Challenge Bioproducts.

Explore the full profile